THYE DIRK (Chief Executive Officer) received a stock award from QUINCE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/23/2025ACC: 0000912282-25-000695
DirectorOfficer· Chief Executive Officer
Since May 2022
+301.89K
Net shares
Net buyer
$181.1K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
301.89K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+150.94K
Price / share
$1.20
Trade value
$181.13K
% of position
17.9%
6/18/2025
843.94K→994.88K
Total
Net shares
+150.94K
Net value
$181.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/18/2025 | A · Award | +150.94K | $1.20 | $181.13K | 17.9% | 843.94K | 994.88K |
| Total | +150.94K | $181.13K | ||||||
Derivative Transactions1
Warrants
Direct
Converts to
Common Shares
150.94K shares
Shares
+150.94K
Strike price
1.2
Held after
150.94K
Exercisable
—
6/18/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants Direct | Common Shares150.94K shares | 6/18/2025 | A · Award | +150.94K | 1.2 | — | 150.94K |